Anne R. Mccall to Human papillomavirus 16
This is a "connection" page, showing publications Anne R. Mccall has written about Human papillomavirus 16.
Connection Strength
0.176
-
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 07 01; 107(3):487-498.
Score: 0.176